Relationship to Insulin Resistance of the Adult Treatment Panel III Diagnostic Criteria for Identification of the Metabolic Syndrome
- Karen L. Cheal1,
- Fahim Abbasi2,
- Cindy Lamendola2,
- Tracey McLaughlin2,
- Gerald M. Reaven2 and
- Earl S. Ford3
- 1Department of Psychiatry, Brigham and Women’s Hospital, Boston, Massachusetts
- 2Department of Medicine, Stanford University School of Medicine, Stanford, California
- 3Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
- Address correspondence and reprint requests to Gerald M. Reaven, MD, Division of Cardiovascular Medicine, Falk CVRC, Stanford Medical Center, 300 Pasteur Drive, Stanford, CA 94305-5406. E-mail: greaven{at}cvmed.stanford.edu
Abstract
The Adult Treatment Panel III (ATP III) has published criteria for diagnosing the metabolic syndrome, a cluster of closely related abnormalities related to insulin resistance that increase cardiovascular disease risk. The present analysis was performed to evaluate the ability of these criteria to identify insulin-resistant individuals. The population consisted of 443 healthy volunteers, with measurements of BMI, blood pressure, fasting plasma glucose, triglycerides, HDL cholesterol concentrations, and steady-state plasma glucose (SSPG) concentration. Insulin resistance was defined as being in the top tertile of SSPG concentrations. Of the population, 20% satisfied ATP III criteria for the metabolic syndrome. Although insulin resistance and the presence of the metabolic syndrome were significantly associated (P < 0.001), the sensitivity and positive predictive value equaled 46% (69 of 149) and 76% (69 of 91), respectively. Being overweight, with high triglycerides, low HDL cholesterol, or elevated blood pressure, most often resulted in a diagnosis of the metabolic syndrome. Thus, the ATP III criteria do not provide a sensitive approach to identifying insulin-resistant individuals. The individual components vary both in terms of their utility in making a diagnosis of the metabolic syndrome and their relationship to insulin resistance, with the obesity and lipid criteria being most useful.
- ADA, American Diabetes Association
- ATP III, Adult Treatment Panel III
- CVD, cardiovascular disease
- NHANES III, Third National Health and Nutrition Examination Survey
- SSPG, steady-state plasma glucose
- SSPI, steady-state plasma insulin
- WOSCOPS, West of Scotland Coronary Prevention Study
Footnotes
-
- Accepted February 4, 2004.
- Received December 1, 2003.
- DIABETES














